Precigen, Inc.

Historical 13F Holders

Reported Value, Excluding Options

Total Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 74017N105 since 12/18/2024, newest first.

Filer	% of Class	Shares	Form	Filed
Point72 Asset Management, L.P. 13G/A Amendment 1	1.9%	6,741,861	13G/A Amendment 1	5/15/2026 Event 3/31/2026
Point72 Asset Management, L.P.	1.9%	6,741,861
Point72 Capital Advisors, Inc.	1.9%	6,741,861
Steven A. Cohen	1.9%	6,741,861
Patient Capital Management, LLC 13G/A Amendment 4	10.2%	36,006,800	13G/A Amendment 4	2/13/2026 Event 12/31/2025
Patient Capital Management, LLC	10.2%	36,006,800
Patient Opportunity Trust, a Series of Advisor Managed Portfolios	7.8%	27,617,612
Point72 Asset Management, L.P. 13G	5.2%	18,383,242	13G	1/23/2026 Event 1/22/2026
Point72 Asset Management, L.P.	5.2%	18,383,242
Point72 Capital Advisors, Inc.	5.2%	18,383,242
Steven A. Cohen	5.2%	18,383,242
Patient Capital Management, LLC 13G/A Amendment 3	13.6%	45,223,463	13G/A Amendment 3	10/30/2025 Event 12/31/2024
Patient Capital Management, LLC	13.6%	45,223,463
Patient Opportunity Trust, a Series of Advisor Managed Portfolios	11.0%	35,786,370
Miller William H III 13G	9.2%	34,051,925	13G	9/23/2025 Event 6/26/2025
Patient Capital Management, LLC 13G/A Amendment 2	6.5%	17,683,758	13G/A Amendment 2	2/12/2025 Event 12/31/2024

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2026 Q3	32	4.97 M	$42.5 M	$0
2026 Q2	225	142 M	$1.02 B	$29.1 M
2026 Q1	214	134 M	$517 M	$11.3 M
2025 Q4	190	136 M	$570 M	$11.1 M
2025 Q3	179	112 M	$369 M	$28.9 M
2025 Q2	158	82.4 M	$117 M	$2.15 M
2025 Q1	149	80.3 M	$125 M	$1.71 M
2024 Q4	138	75.8 M	$84.8 M	$154 k
2024 Q3	136	76.3 M	$72.5 M	$285 k
2024 Q2	137	62.8 M	$99.2 M	$546 k
2024 Q1	138	65.1 M	$94.3 M	$365 k
2023 Q4	145	65.5 M	$87.8 M	$64.7 k
2023 Q3	144	60.6 M	$86.0 M	$87.9 k
2023 Q2	144	57.4 M	$66.0 M	$116 k
2023 Q1	165	61.6 M	$65.3 M	$235 k
2022 Q4	175	44.4 M	$67.5 M	$586 k
2022 Q3	179	125 M	$266 M	$954 k
2022 Q2	181	136 M	$182 M	$539 k
2022 Q1	188	144 M	$304 M	$2.31 M
2021 Q4	187	144 M	$533 M	$5.03 M
2021 Q3	190	138 M	$690 M	$5.22 M
2021 Q2	170	142 M	$926 M	$7.40 M
2021 Q1	181	142 M	$979 M	$7.58 M
2020 Q4	177	122 M	$1.25 B	$21.5 M
2020 Q3	182	124 M	$434 M	$4.15 M
2020 Q2	178	122 M	$609 M	$5.81 M
2020 Q1	171	133 M	$450 M	$3.55 M
2019 Q4	5	228 k	$1.15 M	$0
2019 Q3	1	42.9 k	$279 k	$0
2019 Q2	1	42.9 k	$279 k	$0
2019 Q1	1	42.9 k	$279 k	$0
2016 Q1	1	375	$12.7 k	$0